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Abstract
The current guidelines for managing cardiogenic shock lack specificity and clarification. The main criterion for cardiogenic
shock is low cardiac output, and the most important goal is to achieve adequate output from a shock state. Because of the
complex nature of cardiogenic shock, a “one-size-fits-all" outline may not be the best solution. Historically, hemodynamic
goals in cardiogenic shock are copied from septic shock. Because septic shock and cardiogenic shock are different
hemodynamic entities, the goals should be different.
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Background
In a statement from the American Heart Association on
critical care unit monitoring, there is only one paragraph that
outlines the hemodynamic goals to manage cardiogenic shock.
It states:
The optimal [mean arterial pressure] MAP likely differs
from patient to patient, and the risks of hypoperfusion with
lower MAPs must be balanced (and individualized) with the
potentially deleterious impact of vasoactive agents on
myocardial oxygen demand, ischemia, and arrhythmia
associated with higher MAP targets.1
While certainly appropriate, the guidelines lack direct and
specific goals for managing cardiogenic shock. Any
recommendations come from studies of septic shock. In
contrast, guidelines on septic shock are clear and specific.

The guidelines from the Surviving Sepsis Campaign 2 state
similar goals:
•
•
•
•

Central venous pressure (CVP) of 8-12 mmHg
Mean arterial pressure (MAP) greater than 65 mmHg
Mixed venous saturation (SvO2) greater than 65%
Urine output greater than 0.5 mL kg h-1

Septic and cardiogenic shock studies in the context of
guideline refinement will be reviewed.

Studies Related to Septic Shock
The Surviving Sepsis Campaign referenced a randomized
trial comparing goal-directed therapy to standard therapy.3
The in-hospital mortality for goal-directed therapy was 30.5%
versus 46.5% with standard therapy.
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A post hoc data analysis of a multicenter trial investigated
the association of MAP and vasopressor load in septic shock
patients.4 Similar mortality rates were seen when patients were
grouped into quartiles based on MAP (from 70-100 mm Hg).
When the quartiles were based on vasopressor load and dose,
there was a stepwise increase in mortality with each increasing
quartile.
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We need to design and conduct randomized trials in
patients with cardiogenic shock to define appropriate
hemodynamic goals for each type of shock of cardiogenic
origin. For any type of shock, the specific goals should provide
guidance to achieve normal cardiac output, adequate perfusion
of end organs, and an euvolemic state.

Conclusion
In a retrospective study evaluating arterial blood pressure
during sepsis and outcome, the best results were seen in
patients with a MAP between 60 and 65 mmHg. 5 The time
spent below these values correlated with increased mortality
risk, with an odds ratio of 2.96.

Septic Shock versus Cardiogenic Shock
Septic shock and cardiogenic shock are hemodynamically
different. They share some common features, such as endorgan hypoperfusion, tissue hypoperfusion, and cardiac index
but differ in cardiac output, wedge pressure, CVP, etc.
Because they are entirely different entities, the hemodynamic
goals for septic shock should not be applied to the cardiogenic
shock setting. This is especially important since not all
cardiogenic shock cases are created equal.
Cardiogenic shock can be caused by a pulmonary
embolism and acute right ventricular failure with an
underfilled ventricle that creates low cardiac output. 6
Cardiogenic shock can result from acute myocardial infarction
with left ventricular failure, high wedge pressure, and normal
right atrial pressure. Depending on ideology, there are
differences in how patients go into cardiogenic shock.
Hypertension, hypoperfusion, decreased cardiac output, and
possible congestion are all commonly seen after the immediate
impact of arterial occlusion in acute myocardial infarctionrelated shock. The same can also be seen in cardiogenic shock
caused by heart failure; however, the process is gradual rather
than acute. To curate more specific priorities and
hemodynamic goals for managing cardiogenic shock, the
differences between cardiogenic shock and septic shock, and
even the different etiologies of cardiogenic shock, need to be
further explored through prospective studies.
There are different mortality profiles depending on the
type of congestion.7 Right ventricular congestion, left
ventricular congestion, and bi-ventricular congestion exist,
and all are seen in patients with cardiogenic shock. Right
ventricular and bi-ventricular congestion carry higher
mortality risks than left ventricular congestion. In the setting
of acute myocardial infarction, left ventricular congestion
carries a higher risk of mortality than heart failure-related
shock.
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The main criterion for cardiogenic shock is low cardiac
output, and the most important goal is to achieve adequate
cardiac output from a shock state. There may not be a “one
size fits all” solution because of the variety of cardiogenic
shock types; however, the current guidelines for goal-directed
management need further clarification and specificity. For any
type of cardiogenic shock, we need to achieve normal cardiac
output, adequate perfusion of end organs, and an euvolemic
state. Prospective studies comparing and investigating
different sets of goals are needed.
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